Drug Trial Radar · NCT02770716
Study To Confirm Efficacy and Safety of Terlipressin in Hepatorenal Syndrome (HRS) Type 1
Last checked: Nov 20, 2026Latest source record: Nov 29, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
300
Actual
Start
Jul 13, 2016
Primary completion
Jul 24, 2019
Study completion Jul 24, 2019
Sponsor
- Lead sponsor
- MallinckrodtIndustry
- Sponsor type
- Industry
- First posted
- May 12, 2016
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is to treat adult patients with hepatorenal syndrome (HRS) Type 1. Out of every three participants, two will receive terlipressin and one will receive placebo. Assignments will be made randomly.
Conditions
- Hepatorenal Syndrome
Interventions
TerlipressinDrug
Terlipressin solution for injection
PlaceboOther
Matching placebo solution for injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With Verified HRS ReversalTime frame: within 15 Days
- Percentage of Participants Who Were Viable (Per Protocol) for Inclusion in the Primary End Point AnalysisTime frame: within 25 days
Locations
64 sites in 2 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama
Banner Good Samaritan Medical Center
Phoenix, Arizona
Mayo Clinic - AZ
Phoenix, Arizona
University of Arizona
Tucson, Arizona
USC Healthcare
Los Angeles, California
Stanford Hospital and Clinics
Palo Alto, California
UCLA Medical Center
San Diego, California
Southern California Research Center
San Diego, California
California Pacific Medical Center
San Francisco, California
MedStar Georgetown University Hospital
Washington D.C., District of Columbia
University of Florida
Gainesville, Florida
Mayo Clinic - FL
Jacksonville, Florida
Jackson Memorial Hospital
Miami, Florida
University of Miami
Miami, Florida
Tampa General Medical Group
Tampa, Florida
Piedmont Hospital Transplant
Atlanta, Georgia
Emory University Hospital
Atlanta, Georgia
Northwestern University
Chicago, Illinois
Rush University Medical Center
Chicago, Illinois
University of Iowa Hospitals & Clinics
Iowa City, Iowa
University of Kansas Medical Center
Kansas City, Kansas
Ochsner Clinic Foundation
New Orleans, Louisiana
Mercy Medical Center
Baltimore, Maryland
Beth Israel Deaconess Medical Center
Boston, Massachusetts
University of Michigan Medical Center
Ann Arbor, Michigan
University of Minnesota
Minneapolis, Minnesota
Mayo Clinic - MN
Rochester, Minnesota
Saint Louis University
St Louis, Missouri
Washington University in St. Louis
St Louis, Missouri
University of Nebraska Medical Center
Omaha, Nebraska
Rutgers New Jersey Medical School
Newark, New Jersey
NYU Langone Health
New York, New York
Weil Cornell Medical College
New York, New York
Mount Sinai Medical Center
New York, New York
Montefiore Medical Center
The Bronx, New York
Case Western Reserve Transplant
Cleveland, Ohio
The Ohio State University Wexner Medical Center
Columbus, Ohio
INTEGRIS Baptist Medical Center
Oklahoma City, Oklahoma
Drexel University
Philadelphia, Pennsylvania
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania
Showing 40 of 64 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.